Vital Farms Logo.png
Vital Farms on Track to Deliver Strong Growth in 2025 with Key Investments in Resilient Supply Chain and Farm Network Expansion
January 13, 2025 08:00 ET | Vital Farms
AUSTIN, Texas, Jan. 13, 2025 (GLOBE NEWSWIRE) -- Vital Farms (Nasdaq: VITL), a Certified B Corporation that offers a range of ethically produced foods nationwide, today announced that it is...
goldansatate-logo-blk-300x300.png
Pointwealth Capital Management Welcomes Glenn Hruska and Expands Assets Under Management to Over $450 Million
January 13, 2025 08:00 ET | Golden State
Pointwealth Capital Management is proud to announce the acquisition of Glenn Hruska.
life.jpg
LifeVantage Study Confirms Breakthrough Synergistic Effects of Healthy Weight Stack*
January 13, 2025 08:00 ET | LifeVantage Corporation
SALT LAKE CITY, Jan. 13, 2025 (GLOBE NEWSWIRE) -- LifeVantage Corporation (Nasdaq: LFVN), a leader in cellular activation of optimal health processes, today announced the results of a groundbreaking...
SalariusLogo2ColorNoTag.jpg
Salarius Pharmaceuticals and Decoy Therapeutics Announce Definitive Merger Agreement
January 13, 2025 08:00 ET | Salarius Pharmaceuticals, Inc.
Decoy’s proprietary IMP3ACT™ peptide conjugate drug design and manufacturing platform leverages machine learning (ML) and artificial intelligence (AI) tools Decoy is leveraging non-dilutive funding...
ekso.jpg
Ekso Bionics Reports Certain Preliminary Fourth Quarter 2024 Financial Results
January 13, 2025 08:00 ET | Ekso Bionics Holdings, Inc.
Expects Record Revenues for the Fourth Quarter of 2024 SAN RAFAEL, Calif., Jan. 13, 2025 (GLOBE NEWSWIRE) -- Ekso Bionics Holdings, Inc. (Nasdaq: EKSO) (the “Company”), an industry leader in...
ORIC.png
ORIC Pharmaceuticals Announces Clinical Supply Agreement to Evaluate ORIC-114 in Combination with Amivantamab for the First-Line Treatment of NSCLC with EGFR Exon 20 Insertion Mutations
January 13, 2025 08:00 ET | ORIC Pharmaceuticals
SOUTH SAN FRANCISCO, Calif. and SAN DIEGO, Jan. 13, 2025 (GLOBE NEWSWIRE) -- ORIC Pharmaceuticals, Inc. (Nasdaq: ORIC), a clinical stage oncology company focused on developing treatments that...
Apyx_medical_logo.jpg
Apyx Medical Corporation Reports Preliminary Fourth Quarter and Full Year 2024 Revenue Results
January 13, 2025 08:00 ET | Apyx Medical Corporation
CLEARWATER, Fla, Jan. 13, 2025 (GLOBE NEWSWIRE) -- Apyx Medical Corporation (NASDAQ:APYX) (the “Company”), the manufacturer of a proprietary helium plasma and radiofrequency technology marketed and...
Huma Logo.png
Humacyte Provides Update on Commercial Launch and Pricing of Symvess™ (acellular tissue engineered vessel-tyod) for Extremity Vascular Trauma
January 13, 2025 08:00 ET | Humacyte, Inc
– Symvess is a first-in-class bioengineered human tissue designed to be a universally implantable vascular conduit for use in arterial replacement and repair – – Highly experienced sales team...
GreenridgeExploration_COL_LOGO@4x.png
Greenridge Exploration Announces Results of its 2024 Exploration Program at its Carpenter Lake Uranium Project in the Athabasca Basin
January 13, 2025 08:00 ET | Greenridge Exploration Inc.
Highlights Confirmation and locations of multiple high priority targets were identified and mapped. These locations will be further explored in preparation for future drilling.Twenty-two (22)...
yogapodlogo.png
Boulder’s Yoga Pod celebrates 15 years of local ownership and community building
January 13, 2025 08:00 ET | Yoga Pod
BOULDER, Colo, Jan. 13, 2025 (GLOBE NEWSWIRE) --  Yoga Pod celebrates 15 years under the leadership of owners Nicole and Gerry Wienholt in February, recognizing impressive growth and community...